Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Download original image
Fig. 6. Quantification of changes in glial fibrillary acidic protein (GFAP) expression in different brain regions. GFAP expression in the hippocampus and amygdala was quantified (ImageJ software; NIH, Bethesda, MD, USA) and expressed as a percentage of tissue area. (A) GFAP expression changes in hippocampus. (B) GFAP expression changes in amygdala. (C) GFAP expression changes in hypothalamus. Like mRNA expression changes in hippocampus, GFAP expression pattern changed after dextran sodium sulfate exposure. *Significance (p<0.05).
Clinical Psychopharmacology and Neuroscience 2018;16:422~433 https://doi.org/10.9758/cpn.2018.16.4.422
© Clin Psychopharmacol Neurosci